PDF herunterladen
Klin Monbl Augenheilkd 2005; 222(7): 568-571
DOI: 10.1055/s-2005-858433
Klinische Studie

© Georg Thieme Verlag KG Stuttgart · New York

Ultrastrukturelle Veränderungen in der Struktur epiretinaler Membranen bei PVR - Anspruch und Wirklichkeit

Alterations in the Structure of the Epiretinal Membranes in PVR - Assumptions and RealityC. Vidinova1 , L. Voinov1 , N. Vidinov2
  • 1Clinic of Ophthalmology, Military Medical Academy, Sofia
  • 2Department of Anatomy and Histology, Medical University, Sofia
Weitere Informationen

Publikationsverlauf

Eingegangen: 8.12.2004

Angenommen: 25.4.2005

Publikationsdatum:
21. Juli 2005 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Hintergrund: Die proliferative Vitreoretinopathie (PVR) ist eine häufige Komplikation der chirurgischen Behandlung von rhegmatogenen Netzhautablösungen. Ziel unserer Untersuchung ist, die ultrastrukturellen Veränderungen in der Struktur epiretinaler Membranen bei PVR zu dokumentieren. Methoden: Innerhalb dieser prospektiven Untersuchung wurden Membranen während der Vitrektomie von 64 PVR-Patienten entnommen. Die wurden später ultrastrukturell im Transmissions- und Rasterelektronenmikroskop analysiert. Ergebnisse: In den frühen Stadien der PVR bestanden die Membranen meistens aus Pigmentepithelzellen (RPE), Fibroblasten und wenigen Glialzellen. In einigen RPE-Zellen haben wir morphologische Veränderungen objektiviert. Bei Patienten mit fortgeschrittener PVR enthielten die Membranen meistens vorwiegend spindelförmige Fibroblasten. Die Zahl der RPE-Zellen war deutlich vermindert. Schlussfolgerung: Unsere Ergebnisse weisen darauf hin, dass epiretinale Membranen nicht stabile, sondern dynamische Strukturen sind, die ständig Zell- und Matrix-Verfassung wechseln können. In Wirklichkeit müssen wir klinische und auch morphologische Veränderungen berücksichtigen, um die bessere therapeutische Behandlung auszuwählen.

Abstract

Background: Proliferative vitreoretinopathy (PVR) is known to be the main cause of failure for routine retinal detachment surgery. Our aim was to document the ultrastructural changes in the epiretinal membranes in cases of PVR. Material and Methods: Epiretinal membranes were taken during vitrectomy of 64 patients with different stages of PVR and further analysed using transmission and scanning electron microscopy. Results: In the early stages of the disease mainly retinal pigment epithelial (RPE) cells, fibroblasts and occasional glial cells were found. Moreover, some of the RPE cells showed altered characteristics. In contrast, epiretinal membranes from the developed stages of PVR were comprised mostly of fibroblasts and a considerably diminished number of RPE cells. Cells with marks of degeneration were generally found. Conclusions: Our results point out that epiretinal membranes in PVR are dynamic structures, constantly changing their cell and matrix composition with the progression of the disease. The morphological changes together with the clinical data are important points to consider when discussing the most appropriate therapeutic approach for each case.

Schlüsselwörter

Netzhautablösungen - PVR - Vitrektomie - OCT - Elektronenmikroskop - epiretinale Membranen

Key words

Retinal detachment - PVR - vitrectomy - OCT - electron microscopy - epiretinal membranes

Literatur

  • 1 Akira A. et al . Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.  Br J Ophthalmol. 2000;  84 1306-1311
    CrossrefPubMedGoogle Scholar
  • 2 Anderson D. et al . The onset of pigment epithelial proliferation after retinal detachment.  Invest Opthalmol Vis Sci. 1981;  21 10-16
    PubMedGoogle Scholar
  • 3 Asaria Y, Kon C, Bunce C. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy.  Ophthalmology. 2001;  108 1179-1183
    CrossrefPubMedGoogle Scholar
  • 4 Araiz J, Refojo M, Arroyo M. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.  Invest Ophthalmol Vis Sci. 1993;  34 522-530
    PubMedGoogle Scholar
  • 5 Bellhorn M. et al . Ultrastructure and clinicopathologic correlation of idiopathic preretinal macular fibrosis.  Am J Ophtalmol. 1975;  79 366-373
    PubMedGoogle Scholar
  • 6 Campochiaro P, Jerdan J, Glasser B. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro.  Invest Ophthalmol Vis Sci. 1986;  27 1615-1621
    PubMedGoogle Scholar
  • 7 Campochiaro P. et al . The retinal pigmented epithelium and retinal wound repair.  Great Basin Visual Science Symposium. 1996;  2 28-34
    PubMedGoogle Scholar
  • 8 Casaroli-Marano P, Pagan R, Vilaro S. Epiretinal mesenchimal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in retinal pigment epithelial cells.  Invest Ophthalmol Vis Sci. 1999;  40 2062-2072
    PubMedGoogle Scholar
  • 9 Chandler D. et al . The effect of triamcinolone acetonide on a defined experimental model of proliferative vitreoretinopathy.  Am J Ophthalmol. 1985;  99 686-690
    PubMedGoogle Scholar
  • 10 Chapman C, Inverson D. The effect of low molecular weight heparin on proliferative vitreoretinopathy induced in the rabbit eye.  Invest Ophthalmol Vis Sci. 1992;  33 (Suppl 1) 818-820
    PubMedGoogle Scholar
  • 11 Charteris D. Proliferative vitreoretinopathy: pathology, surgical management, and adjunctive treatment.  British J Ophthalm. 1995;  79 953-960
    CrossrefPubMedGoogle Scholar
  • 12 Chee H, Nicolas L, Peng T. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study.  Invest Opthalmol Vis Sci. 1999;  40 705-733
    PubMedGoogle Scholar
  • 13 Clarkson J, Green W, Massof D. A histopathological review of 168 cases of preretinal membrane.  Am J Ophthalmol. 1992;  3 357-365
    PubMedGoogle Scholar
  • 14 Cowley M, Conway B, Campochiaro P. Clinical risk factors for proliferative vitreoretinopathy.  Arch Ophthalmology. 1983;  90 121-125
    PubMedGoogle Scholar
  • 15 Committee TRUST . The classification of retinal detachment with proliferative vitreoretinopathy.  Ophthalmology. 1983;  90 121-125
    PubMedGoogle Scholar
  • 16 Fisher S, Erickson P, Lewis G. et al . Intraretinal proliferation induced by retinal detachment.  Invest Ophthalmol Vis Sci. 1991;  32 1739-1748
    PubMedGoogle Scholar
  • 17 Foos R. et al . Vitreoretinal Juncture - simple epiretinal membranes.  Albrecht von Graefes Arch Klin Ophthalmol. 1974;  189 231-250
    PubMedGoogle Scholar
  • 18 Garthner J. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistichemical study.  Br J Ophthalmol. 1981;  69 810-823
    PubMedGoogle Scholar
  • 19 Gidry C. et al . Collagen gel contraction by cells associated with proliferative vitreoretinopathy.  Invest Ophthalmol Vis Sci. 1992;  33 2429-2435
    PubMedGoogle Scholar
  • 20 Glaser B, Cardin A, Biscoe B. Proliferative vitreoretinopathy: the mechanism of development of vitreoretinal traction.  Ophthalmology. 1987;  94 327-332
    CrossrefPubMedGoogle Scholar
  • 21 Hariot W, Machemer R. Pigment epithelial repair.  Graefes Arch Clin Exp Ophthalmol. 1992;  230 91-100
    CrossrefPubMedGoogle Scholar
  • 22 Hiscott P, Grierson I, Mc Leod D. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study.  Br J Ophthalmol. 1984;  68 695-698
    PubMedGoogle Scholar
  • 23 Jerdan J, Pepose J, Michels R. Proliferative vitreoretinopathy membranes: An immunochistochemical study.  Ophthalmology. 1989;  96 (14) 801-810
    PubMedGoogle Scholar
  • 24 Kon C, Occleston N. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.  Invest Ophthalmol Vis Sci. 1999;  40 705-712
    PubMedGoogle Scholar
  • 25 Machemer R, Laqua H. A logical approach to the treatment of massive preretinal proliferation.  Ophthalmology. 1978;  85 584-593
    PubMedGoogle Scholar
  • 26 Pauleikhoff D, van Kuijk F, Bird A. Makuläres Pigment und AMD.  Ophthalmologe. 2001;  98 511-519
    CrossrefPubMedGoogle Scholar
  • 27 Rachel W, Burton T. Changing concepts of failures after retinal detachment surgery.  Arch Ophthalmol. 1979;  97 480-483
    PubMedGoogle Scholar
  • 28 Rachel W, Burton T. The classification of retinal detachment with proliferative vitreoretinopathy.  Ophthalmology. 1983;  90 121-125
    PubMedGoogle Scholar
  • 29 Sebestyen J. et al . Fibrinoid syndrome: A severe complication of vitrectomy surgery in diabetics.  Ann Ophthalmol. 1982;  14 853-856
    PubMedGoogle Scholar
  • 30 Vinores S. et al . Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia and fibroblasts in vitreous culture.  Invest Ophthalmol Vis Sci. 1990;  31 2529-2545
    PubMedGoogle Scholar
  • 31 Vinores S. et al . A morphological and immunohistochemical study of human retinal pigment epithelial cells, retinal glia and fibroblasts grown on Gelform matrix in an organ culture system.  Graefes Arch Clin Exp Ophthalmol. 1993;  231 279-288
    CrossrefPubMedGoogle Scholar
  • 32 Weler M, Wiedemann P. Proliferative vitreoretinopathy - is it anything more than wound healing at the wrong place?.  Int Ophthalmol. 1990;  14 105-117
    CrossrefPubMedGoogle Scholar
  • 33 Wiedemann P, Hilgers R. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.  Graefes Arch Clin Exp Ophthalmol. 1991;  229 150-152
    CrossrefPubMedGoogle Scholar
  • 34 Wiedemann P, Lemmen K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy.  Am J Ophthalmol. 1987;  104 10-14
    CrossrefPubMedGoogle Scholar
  • 35 Yang C, Khawly J, Chen S. An intravitreal sustained release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.  Arch Ophthalmol. 1998;  116 69-77
    PubMedGoogle Scholar

Dr. Christina Nicolaeva Vidinova

„Khan Asparuh” Str. 27

Sofia 1463

eMail: christinavidinova@yahoo.com

      >